BVF INC/IL Diversified Active

CIK: 0001056807 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 14, 2017

Total Value ($000): $497,725 (99.4% shares, 0.6% debt)

Holdings (29)

— BLUEPRINT MEDICINES CORP 18.3%

Value ($000) $91,311 Shares 3,255,280 Est. Cost $25.16 Unrealized —

CYTK CYTOKINETICS INC 11.8%

Value ($000) $58,948 Shares 4,851,691 Est. Cost $7.03 Unrealized +50.9%

— CHEMOCENTRYX INC 11.6%

Value ($000) $57,709 Shares 7,798,572 Est. Cost $8.96 Unrealized —

— ARRAY BIOPHARMA INC 8.8%

Value ($000) $43,829 Shares 4,986,186 Est. Cost $4.28 Unrealized —

— CONCERT PHARMACEUTICALS INC 5.4%

Value ($000) $26,921 Shares 2,616,249 Est. Cost $13.78 Unrealized —

XENE XENON PHARMACEUTICALS INC 4.7%

Value ($000) $23,437 Shares 3,043,805 Est. Cost $9.33 Unrealized -13.9%

— FORWARD PHARMA A/S 4.2%

Value ($000) $20,832 Shares 1,387,853 Est. Cost $20.85 Unrealized —

— CTI BIOPHARMA CORP 3.6%

Value ($000) $18,053 Shares 44,796,940 Est. Cost $1.27 Unrealized —

— COLUCID PHARMACEUTICALS INC 3.5%

Value ($000) $17,630 Shares 484,335 Est. Cost $38.15 Unrealized —

— GLYCOMIMETICS INC 3.5%

Value ($000) $17,240 Shares 2,826,282 Est. Cost $7.10 Unrealized —

— ONCOMED PHARMACEUTICALS INC 2.7%

Value ($000) $13,573 Shares 1,760,489 Est. Cost $16.92 Unrealized —

— CASCADIAN THERAPEUTICS INC 2.7%

Value ($000) $13,504 Shares 3,133,224 Est. Cost $4.31 Unrealized —

INFIQ INFINITY PHARMACEUTICALS INC 2.1%

Value ($000) $10,612 Shares 7,860,808 Est. Cost $3.51 Unrealized -62.8%

— ACHILLION PHARMACEUTICALS INC COM 2.0%

Value ($000) $10,008 Shares 2,423,300 Est. Cost $4.13 Unrealized —

FATE FATE THERAPEUTICS INC 1.9%

Value ($000) $9,436 Shares 3,759,398 Est. Cost $2.68 Unrealized 0.0%

— ARQULE INC 1.9%

Value ($000) $9,324 Shares 7,400,128 Est. Cost $1.87 Unrealized —

ESPR ESPERION THERAPEUTICS INC NE 1.8%

Value ($000) $8,924 Shares 712,770 Est. Cost $14.80 Unrealized -19.6%

— ADURO BIOTECH INC 1.7%

Value ($000) $8,503 Shares 745,886 Est. Cost $11.34 Unrealized —

— IMMUNE DESIGN CORP 1.5%

Value ($000) $7,261 Shares 1,320,164 Est. Cost $7.39 Unrealized —

CTMX CYTOMX THERAPEUTICS INC 1.2%

Value ($000) $6,097 Shares 554,806 Est. Cost $15.82 Unrealized -23.4%

— GTX INC DEL 1.2%

Value ($000) $5,853 Shares 1,108,433 Est. Cost $5.28 Unrealized —

— SUNESIS PHARMACEUTICALS INC 1.0%

Value ($000) $5,042 Shares 1,392,720 Est. Cost $4.01 Unrealized —

— NIVALIS THERAPEUTICS INC 0.8%

Value ($000) $4,176 Shares 1,864,474 Est. Cost $6.12 Unrealized —

— OREXIGEN THERAPEUTICS INC 0.6%

Value ($000) $3,000 Shares 10,000,000 Est. Cost $0.27 Unrealized —

— PIERIS PHARMACEUTICALS INC 0.5%

Value ($000) $2,606 Shares 1,854,768 Est. Cost $1.61 Unrealized —

— PAIN THERAPEUTICS INC 0.3%

Value ($000) $1,299 Shares 2,278,552 Est. Cost $1.80 Unrealized —

— OREXIGEN THERAPEUTICS INC 0.3%

Value ($000) $1,279 Shares 734,976 Est. Cost $3.32 Unrealized —

XOMA XOMA CORP DEL 0.3%

Value ($000) $1,278 Shares 302,800 Est. Cost $6.20 Unrealized 0.0%

— ANTHERA PHARMACEUTICALS INC 0.0%

Value ($000) $40 Shares 62,292 Est. Cost $0.64 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	BLUEPRINT MEDICINES CORP	3,255,280	$91,311	18.3%	$25.16	—	COM	09627Y109
CYTK	CYTOKINETICS INC	4,851,691	$58,948	11.8%	$7.03	+50.9%	COM NEW	23282W605
—	CHEMOCENTRYX INC	7,798,572	$57,709	11.6%	$8.96	—	COM	16383L106
—	ARRAY BIOPHARMA INC	4,986,186	$43,829	8.8%	$4.28	—	COM	04269X105
—	CONCERT PHARMACEUTICALS INC	2,616,249	$26,921	5.4%	$13.78	—	COM	206022105
XENE	XENON PHARMACEUTICALS INC	3,043,805	$23,437	4.7%	$9.33	-13.9%	COM	98420N105
—	FORWARD PHARMA A/S	1,387,853	$20,832	4.2%	$20.85	—	SPONSORED ADR	34986J105
—	CTI BIOPHARMA CORP	44,796,940	$18,053	3.6%	$1.27	—	COM	12648L106
—	COLUCID PHARMACEUTICALS INC	484,335	$17,630	3.5%	$38.15	—	COM	19716T101
—	GLYCOMIMETICS INC	2,826,282	$17,240	3.5%	$7.10	—	COM	38000Q102
—	ONCOMED PHARMACEUTICALS INC	1,760,489	$13,573	2.7%	$16.92	—	COM	68234X102
—	CASCADIAN THERAPEUTICS INC	3,133,224	$13,504	2.7%	$4.31	—	COM NEW	14740B606
INFIQ	INFINITY PHARMACEUTICALS INC	7,860,808	$10,612	2.1%	$3.51	-62.8%	COM	45665G303
—	ACHILLION PHARMACEUTICALS INC COM	2,423,300	$10,008	2.0%	$4.13	—	COM	00448Q201
FATE	FATE THERAPEUTICS INC	3,759,398	$9,436	1.9%	$2.68	0.0%	COM	31189P102
—	ARQULE INC	7,400,128	$9,324	1.9%	$1.87	—	COM	04269E107
ESPR	ESPERION THERAPEUTICS INC NE	712,770	$8,924	1.8%	$14.80	-19.6%	COM	29664W105
—	ADURO BIOTECH INC	745,886	$8,503	1.7%	$11.34	—	COM	00739L101
—	IMMUNE DESIGN CORP	1,320,164	$7,261	1.5%	$7.39	—	COM	45252L103
CTMX	CYTOMX THERAPEUTICS INC	554,806	$6,097	1.2%	$15.82	-23.4%	COM	23284F105
—	GTX INC DEL	1,108,433	$5,853	1.2%	$5.28	—	COM NEW	40052B207
—	SUNESIS PHARMACEUTICALS INC	1,392,720	$5,042	1.0%	$4.01	—	COM PAR	867328700
—	NIVALIS THERAPEUTICS INC	1,864,474	$4,176	0.8%	$6.12	—	COM	65481J109
—	OREXIGEN THERAPEUTICS INC	10,000,000	$3,000	0.6%	$0.27	—	NOTE 2.750% 20	686164AB0
—	PIERIS PHARMACEUTICALS INC	1,854,768	$2,606	0.5%	$1.61	—	COM	720795103
—	PAIN THERAPEUTICS INC	2,278,552	$1,299	0.3%	$1.80	—	COM	69562K100
—	OREXIGEN THERAPEUTICS INC	734,976	$1,279	0.3%	$3.32	—	COM NEW	686164302
XOMA	XOMA CORP DEL	302,800	$1,278	0.3%	$6.20	0.0%	COM NEW	98419J206
—	ANTHERA PHARMACEUTICALS INC	62,292	$40	0.0%	$0.64	—	COM NEW	03674U201